GEN-MKT-18-7897-A
Oct 10, 2024 | Blogs, Pharma, QTRAP / Triple Quad | 0 comments
Nitrosamines are a large group of N-nitroso compounds that share a common functional N-N=O group. They are produced by a chemical reaction between a nitrosating agent and a secondary or tertiary amine. Back in 2018, nitrosamines suddenly found themselves in the spotlight when they were unexpectedly detected in medications for high blood pressure. Since then, they have been found in several other prescription medications, including those for heartburn, acid reflux and diabetes, resulting in manufacturers recalling some common medications.
Here are a few examples of how SCIEX solutions can help support the development and manufacturing of pharmaceutical drugs with these analytes.
BH is an H1 receptor agonist and an H3 receptor antagonist, which can be chemically synthesized. The structure of BH includes a secondary amine, which is more reactive in the formation of nitrosamines than the tertiary amines. The regulation has amended the maximum permissible daily intake limit for NNBH as 18 ng/day which is equivalent to a maximum daily dose of 48 mg/day. Given that BH has a maximum daily dose of 48 mg/day, a nitrosamine limit of 0.375 ng/mg is required to be quantified in the API. This technical note presents a reliable workflow for the identification and sensitive quantitation of NNBH in BH API below the calculated specification limit using the QTRAP 4500 system.
Read more, here >
Orphenadrine citrate (OC) is an anticholinergic drug of the etholamine antihistamine class, which can be chemically synthesized. OC has a secondary amine in the structure, which is more reactive in the formation of nitrosamines than the tertiary amines. The regulation has amended the maximum permissible daily intake limit for NNDO as 18 ng/day which applies to a maximum daily dose of 200 mg/day. Given that OC has a maximum daily dose of 200 mg/day, a nitrosamine limit of 90 pg/mg is required to be quantified in the API.
This technical note presents a reliable workflow for the identification and sensitive quantitation of NNDO in OC API below the calculated specification limit using the QTRAP 7500 system.
Read more, here>
SCIEX OS software is a GxP compliance-ready solution integrating data acquisition with the SCIEX time-of-flight mass spectrometers and the SCIEX triple quadrupole systems. Learning just one software allows even less experienced MS users to be trained rapidly to acquire and convert raw MS data into product quality attribute results. The software offers ample flexibility in defining security settings by allowing the creation of customized user roles with different levels of access to the software’s control. Comprehensive and easily readable audit trails guarantee traceability and data integrity.
If you are looking for more information about analyzing nitrosamine impurities by LC-MS, discover our Spotlight on series in which we highlight a different challenging molecule or class of compounds and related LC-MS solutions. Find out more about the nitrosamines featured here.
In monoclonal antibody (mAb) development, assessment of purity and integrity of the protein in question is critical. CE‑SDS is the gold standard assay and is routinely run from analytical development through QC and lot release. It’s trusted because it consistently delivers quantitative, size‑based insight into purity and fragmentation, and it fits naturally into regulated environments.
In drug discovery and development, Metabolite Identification (Met ID) plays a critical role in understanding biotransformation pathways, ensuring safety, and meeting regulatory requirements. Advanced mass spectrometry techniques have revolutionized this process, particularly through electron-based fragmentation methods such as Electron Activated Dissociation (EAD) and Electron Transfer Dissociation (ETD). While both techniques leverage electron interactions to generate informative fragment ions, they differ significantly in mechanism, performance, and suitability for Met ID workflows.
In analytical laboratories, performance is not optional. Whether supporting regulated pharmaceutical workflows, high-throughput CRO operations, clinical reporting, or food and environmental testing, your mass spectrometry and capillary electrophoresis systems are critical to productivity, compliance, and scientific confidence.
Posted by
You must be logged in to post a comment.
Share this post with your network